by NDPH | Sep 6, 2021 | Research
One year after the outbreak of coronavirus disease 2019 (COVID‐19), referrals for persistent headache, often defined as “post‐COVID headache,” have become increasingly common in outpatient headache clinics.
by NDPH | Mar 30, 2021 | Research
New daily persistent headache (NDPH) is an uncommon, treatment-resistant primary headache disorder that was first describe by Vanast in 1986 as a benign syndrome. Elevated TNF-alpha levels on CSF of NDPH patients as a possible cause of this disease.
by NDPH | Nov 26, 2019 | Research
Three main themes were identified: (1) the origin of the illness and seeking answers; (2) characteristics of the pain; and (3) the impact of pain on patients’ lives. The patients precisely recalled the time of onset and the trigger of the pain.
by NDPH | Sep 3, 2019 | Research
A significant number of migraine patients do not find effective and safe treatment to reduce the frequency and severity of their migraine attacks. Hence, a need for newer therapeutic agent exists. In this study, we examined the efficacy and safety of memantine for the...
by NDPH | Jul 15, 2019 | Research
New daily persistent headache (NDPH) presents with a sudden onset headache which continues without remission within 24 h.
by NDPH | May 6, 2019 | Research
New daily persistent headache is a continuous, unremitting headache, notorious for its unresponsiveness to aggressive medical interventions. The underlying pathophysiology of new daily persistent headache is poorly understood resulting in unending, chronic pain.
